Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and pharmacokinetics/pharmacodynamics of intravenous GW328267X in healthy volunteers; the study references acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury

Drugs mentioned

• GW328267X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Injury, Acute | Phase 1 | Status: COMPLETED